摘要
Purpose: Cancer patients heterogeneously develop prognostic awareness, and end-of-life cancer care has become increasingly aggressive to the detriment of patients and healthcare sustainability. We aimed to explore the never-before-examined associations of prognostic-awareness-transition patterns with end-of-life care. Methods: Prognostic awareness was categorized into four states: (1) unknown and not wanting to know; (2) unknown but wanting to know; (3) inaccurate awareness; and (4) accurate awareness. We examined associations of our previously identified three prognostic-awareness-transition patterns during 334 cancer patients’ last 6 months (maintaining accurate prognostic awareness, gaining accurate prognostic awareness, and maintaining inaccurate/unknown prognostic awareness) and end-of-life care (cardiopulmonary resuscitation, intensive care unit care, mechanical ventilation, chemotherapy/immunotherapy, and hospice care) in cancer patients’ last month by multivariate logistic regressions. Results: Cancer patients in the maintaining-accurate-prognostic-awareness and gaining-accurate-prognostic-awareness groups had significantly lower odds of cardiopulmonary resuscitation (adjusted odds ratio [95% confidence interval]: 0.22 [0.06–0.78]; and 0.10 [0.01–0.97], respectively) but higher odds of hospice care (3.44 [1.64–7.24]; and 3.28 [1.32–8.13], respectively) in the last month than those in the maintaining inaccurate/unknown prognostic awareness. The maintaining-accurate-prognostic-awareness group had marginally lower odds of chemotherapy or immunotherapy received than the gaining-accurate-prognostic-awareness group (0.58 [0.31–1.10], p =.096]). No differences in intensive care unit care and mechanical ventilation among cancer patients in different prognostic-awareness-transition patterns were observed. Conclusion: End-of-life care received in cancer patients’ last month was associated with the three distinct prognostic-awareness-transition patterns. Cancer patients’ accurate prognostic awareness should be facilitated earlier to reduce their risk of receiving aggressive end-of-life care, especially for avoiding chemotherapy/immunotherapy close to death. Trial registration: ClinicalTrials.gov:NCT01912846.
原文 | 英語 |
---|---|
頁(從 - 到) | 5975-5989 |
頁數 | 15 |
期刊 | Supportive Care in Cancer |
卷 | 30 |
發行號 | 7 |
DOIs | |
出版狀態 | 已出版 - 07 2022 |
文獻附註
Publisher Copyright:© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.